Mutation Scores and Differential Protein Evaluating Efficacy in Adjuvant Chemotherapy in HER2(-) Luminal B Breast Cancer
Clinical trial NCT03359694 · UNKNOWN
Trial details
- NCT number
- NCT03359694
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-01
- Primary completion
- 2019-11-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.